Preparation and evaluation of oxidized-dextran based on antibacterial hydrogel for synergistic photodynamic therapy

Int J Biol Macromol. 2023 Dec 31;253(Pt 8):127648. doi: 10.1016/j.ijbiomac.2023.127648. Epub 2023 Oct 25.

Abstract

Skin trauma is a widespread, extremely susceptible health issue that affects people all over the world. In this study, an innovative antibacterial hydrogel (ODAA hydrogel) with photosensitizer and antibiotics was developed. Oxidized dextran (ODEX) was used as a carrier to prepare a pH-responsive hydrogel by loading the antibiotic amikacin (AMK) and the photosensitizer hexyl 5-aminolevulinate (HAL) via imine bonds. The ODAA hydrogel has a uniformly distributed cavity structure. The cumulative release rates of HAL and AMK in a simulated inflammatory environment at pH 5.0 were approximately 62.3 % and 71.9 % during 15 days. These results demonstrate the ODAA hydrogel's ability to deliver antibiotics on demand, where the antibiotic content is reduced within the effective range. Regarding the in vitro antibacterial behavior, the combination of HAL and AMK synergistically destroyed the majority of Gram-positive and Gram-negative bacteria through several pathways with broad-spectrum antibacterial effects. ODAA hydrogel has been shown to be biocompatible, nearly non-cytotoxic, and capable of promoting wound healing. It is anticipated that the simultaneous targeted delivery of multiple drugs to lesions in the same carrier at ideal dose ratios for particular therapeutic combinations will produce the most synergistic effects.

Keywords: Antibacterial hydrogel; Hexyl 5-aminolevulinate; Photodynamic therapy.

MeSH terms

  • Amikacin / pharmacology
  • Anti-Bacterial Agents* / pharmacology
  • Dextrans
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Humans
  • Hydrogels / pharmacology
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology

Substances

  • Anti-Bacterial Agents
  • Dextrans
  • Photosensitizing Agents
  • Hydrogels
  • Amikacin